Skip to main content
Have a personal or library account? Click to login
Rational application of fructose-1,6-diphosphate: From the perspective of pharmacokinetics Cover

Rational application of fructose-1,6-diphosphate: From the perspective of pharmacokinetics

Acta Pharmaceutica
Volume 65 (2015): Issue 2 (June 2015)
By: ,  ,  ,   and    
Open Access
|May 2015
References

References

  1. 1. J. E. Cohen, P. Atluri, M. D. Taylor, T. J. Grand, G. P. Liao, C. M. Panlilio, E. E. Suarez, S. E. Zentko, V. M. Hsu, M. F. Berry, M. J. Smith, T. J. Gardner, H. L. Sweeney and Y. J. Woo, Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction, Heart Lung Circ. 15 (2006) 119-123; DOI: 10.1016/j.hlc.2005.12.004.
    Open DOISearch in Google Scholar
  2. 2. L. Galzigna, V. Rizzoli, M. Bianchi, M. P. Rigobello and R. Scuri, Some effects of fructose-1,6-diphosphate on rat myocardial tissue related to a membrane-stabilizing action, Cell Biochem. Funct. 7 (1989) 91-96; DOI: 10.1002/cbf.290070203.
    Open DOISearch in Google Scholar
  3. 3. B. Tavazzi, L. Cerroni, D. D. Pierro, G. Lazzarino, M. Nuutinen, J. W. Starnes and B. Giardina, Oxygen radical injury and loss of high-energy compounds in anoxic and reperfused rat heart: prevention by exogenous fructose-1,6-bisphosphate, Free Radic. Res. 10 (1990) 167-176; DOI: 10.3109/10715769009149885.
    Open DOISearch in Google Scholar
  4. 4. A. K. Markov, Hemodynamics and metabolic effects of fructose 1,6-diphosphate in ischemia and shock-experimental and clinical observations, Ann. Emerg. Med. 15 (1986) 1470-1477; DOI: 10.1016/ S0196-0644(86)80946-5.
    Open DOISearch in Google Scholar
  5. 5. X. T. Wu, J. S. Li, X. F. Zhao, N. Li, Y. K. Ma, W. Zhuang, Y. Zhou and G. Yang, Effects of n-3 fatty acid, fructose-1,6-diphosphate and glutamine on mucosal cell proliferation and apoptosis of small bowel graft after transplantation in rats, World J. Gastroenterol. 9 (2003) 1323-1326.
    Open DOISearch in Google Scholar
  6. 6. T. J. Wheeler, J. M. McCurdy and S. Chien, Permeability of fructose-1,6-bisphosphate in liposomes and cardiac myocytes, Mol. Cell Biochem. 259 (2004) 105-114; DOI: 10.1023/B:MCBI.0000021356.89867.0d.
    Open DOISearch in Google Scholar
  7. 7. T. Kaakinen, A. Naukkarinen, H. Tuominen, P. Romsi, M. Nuutinen, F. Biancari and T. Juvonen, Neuronal ultrastructure is preserved by fructose-1,6-bisphosphate after hypothermic circulatory arrest in pigs, J. Thorac. Cardiov. Sur. 130 (2005) 1475-1476; DOI: 10.1016/j.jtcvs.2005.07.037.
    Open DOISearch in Google Scholar
  8. 8. R. Didlake, K. A. Kirchner, J. Lewin, J. D. Bower and A. K. Markov, Attenuation of ischemic renal injury with fructose 1,6-diphosphate, J. Surg. Res. 47 (1989) 220-226; DOI: 10.1016/0022-4804(89)90111-X.
    Open DOISearch in Google Scholar
  9. 9. N. Antunes, C. A. Martinusso, C. M. Takiya, A. J. Silva, J. F. Ornellas, P. R. Elias, M. Leite, Jr. and L. R. Cardoso, Fructose-1,6-diphosphate as a protective agent for experimental ischemic acute renal failure, Kidney Int. 69 (2006) 68-72; DOI: 10.1038/sj.ki.5000013.
    Open DOISearch in Google Scholar
  10. 10. K. Xu and J. L. Stringer, Pharmacokinetics of fructose-1, 6-diphosphate after intraperitoneal and oral administration to adult rats, Pharmacol. Res. 57 (2008) 234-238; DOI 10.1016/j.phrs.2008.01.008.
    Open DOISearch in Google Scholar
  11. 11. S. Drabant, I. Klebovich, B. Gachalyi, G. Renczes and C. Farsang, Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets, Acta Pharm. Hung. 68 (1998) 294-306.
    Search in Google Scholar
  12. 12. C. S. Won, N. H. Oberlies and M. F. Paine, Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport, Pharmacol. Ther. 136 (2012) 186-201. DOI: 10.1016/j. pharmthera.2012.08.001.
    Search in Google Scholar
  13. 13. L. Yunxia, L. Hongye, X. H. Jiang and C. Peng, Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells, Eur. J. Drug Metab. Ph. 36 (2011) 41-47; DOI: 10.1007/s13318-011-0026-0.
    Open DOISearch in Google Scholar
  14. 14. P. Artursson and J. Karlsson, Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells, Biochem. Bioph. Res. Co. 175 (1991) 880-885; DOI: 10.1016/0006-291X(91)91647-U.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/acph-2015-0020 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 147 - 157
Accepted on: Dec 22, 2014
Published on: May 23, 2015
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
fructose-1,6-diphosphate,
ischemia,
hypoxia,
pharmacokinetics
Related subjects:
Pharmacy,
Pharmacy, other

© 2015 Ting-Ting Li, Jian-Zhong Xie, Ling Wang, Yang-Yang Gao, Xue-Hua Jiang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 65 (2015): Issue 2 (June 2015)
Previous article
Next article